BrightEdge Fund
Corporate VC
BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society. Invests in for-profit companies developing novel cancer-focused therapies and technologies. Deployed $43 million in 21 cancer-focused companies.
Early Stage
Biotech
Healthcare
- Headquarters
- Atlanta, United States
- Website
- acsbrightedge.org
- Last Investment
- Feb 2025
- Geographic Focus
- United States
Investment Thesis
BrightEdge operates at the intersection of investment and innovation to define and catalyze scientific, social, and sustainable impact across the continuum of cancer care, leveraging ACS expertise to invest in oncology startups.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account